Form 4 for PHAT Phathom Pharmaceuticals, Inc.
Accepted 2026-07-16 16:30:48 ET · period of report 2026-07-14 · accession 0001193125-26-306165 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-16 16:30 | 2026-07-14 | PHAT | Breedlove Robert Charles | Principal Accounting Off | F - Tax | $11.04 | -1,555 | 59.9K | -3% | -$17.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-14 | F | D | 1,555 | $11.04 | 59,925 | D | — | — | (F1) Represents shares underlying the restricted stock units that were surrendered by the reporting person to the Issuer in satisfaction of the Issuer's tax withholding obligation. |